Phase III Long Term Extension Study of Ponesimod in Relapsing Multiple Sclerosis: 5-Year Efficacy ResultsF. D. Lublin,A. Singh,M. Ait-Tihyaty,N. Raghavan,M. Pirozek-Lawniczek,T. Sidorenko,L. KapposMULTIPLE SCLEROSIS JOURNAL（2023）引用 0|浏览14AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
